50mg ghk cu GHK-Cu – – Prime Lab Peptides GHK-CU 50 mg - LIVV

doi:10.1016/j.algal.2017.01.011 23

Some feel a difference at 1 mg

Proc Natl Acad Sci 94(14):75317536 Hussain F, Kayani HU (2020) Aging-Oxidative stress, antioxidants and computational modeling

None of GHK-Cu, BPC-157, or TB-500 has an approved human indication, and the GLOW combination specifically has no clinical trial establishing safety or efficacy in humans

The full list includes: BPC-157 (Body Protection Compound-157) TB-500 (Thymosin Beta-4) MOTS-C (Mitochondrial-derived Peptide) GHK-Cu (Copper-binding Tripeptide) Semax (Synthetic ACTH analog) Selank (Synthetic tuftsin analog) DSIP (Delta Sleep-Inducing Peptide) Epithalon (Epithelial Peptide) Kotan (Derivative of Selank) CG-250 (Radiolabeled somatostatin analog, limited clinical use) N-Acetyl Semax (Semax variant) Dihexa (Angiotensin IV analog, nootropic applications) The announcement did not move these peptides to Category 1 a distinction that matters